Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel DMARDs reported by Sumitomo during the ACS meeting

Aug. 30, 2001

Revised Remicade label strengthens warnings about risk of infections

Aug. 27, 2001

Immunex and Wyeth-Ayerst to commence longitudinal rheumatoid arthritis study

Aug. 27, 2001

FDA advisory committee recommends approval of Kineret for treatment of RA

Aug. 22, 2001

Novel MMP inhibitors disclosed by Aventis

Aug. 22, 2001

Cysteine protease inhibitors and their use described by Ono Pharmaceutical

Aug. 21, 2001

SI-6601D found useful for local therapy in rheumatoid arthritis patients

Aug. 20, 2001

Sumitomo describes new compounds for the treatment of inflammation and autoimmune diseases

Aug. 10, 2001

Osteoarthritis product launched in Europe

Aug. 10, 2001

MedImmune begins Vitaxin phase I trials for rheumatoid arthritis

Aug. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...